Editorial team
ioQuanta Research Desk
-
Evidence date ·Why researchers are testing UiO-66 in different sensor designs
Review or Meta-AnalysisA review surveys UiO-66 and hybrid materials in electrochemical sensors for pollutants and biomarkers. Consistent preparation remains a practical challenge.
-
Evidence date ·What can a falling brain resistance reading during sleep reveal?
Peer-Reviewed PaperIn healthy adults, brain impedance fell across the night and during key sleep stages with stimulation. The reading suggests fluid-related change, not proven waste removal.
-
Evidence date ·An electric car’s battery case shapes what can be recovered later
Review or Meta-AnalysisA 2026 review explains how a composite battery case’s plastic, joints and labels affect whether its materials can be separated and recovered.
-
Evidence date ·What changed in old mouse kidneys after eight months of treatment?
Peer-Reviewed PaperAfter eight months of dasatinib and quercetin, aged mice had less kidney scarring and fewer tubular fat droplets. The study did not measure kidney function.
-
Evidence date ·Why finding breast cancer targets may not be enough for CAR-T therapy
Review or Meta-AnalysisA 2026 review examines HER2, EGFR and MUC1 as breast cancer targets, plus tumor diversity and safety risks. Its abstract does not establish patient benefit.
-
Evidence date ·Which generated crystals deserve an expensive property check?
PreprintAt a four-call budget, ranked candidates beat arbitrary picks. In one test, the gate nearly matched exhaustive evaluation while using roughly one-fifth the oracle calls.
-
Evidence date ·Two roles for sugar-based particles in cancer immunotherapy
Review or Meta-AnalysisA review contrasts β-glucan, which can engage immune-cell receptors, with adaptable dextran carriers. Mouse studies and clinical uses answer different questions.
-
Evidence date ·Why might clearing aging cells call for a different immune attack than cancer?
Review or Meta-AnalysisA 2026 review surveys engineered T-cell studies in liver and heart models, then examines target overlap and safety barriers to clearing aging cells in people.
-
Evidence date ·A damaged disc may need its tissue-building cells back
Review or Meta-AnalysisA review proposes clearing aging disc cells, restoring healthy gene activity, then adding replacement cells. Human disc regeneration remains unproven.
-
Evidence date ·How inflammation, fuel use and aging may stiffen the heart
Peer-Reviewed PaperA review connects inflammation, fuel use and aging to impaired heart filling. Some treatments ease symptoms or reduce hospitalizations; survival benefit remains unproven.